Moderna, Inc. MRNA

NASDAQ · Healthcare · Biotechnology

$195.00

Close on Fri, 20 Nov 2026 · market value $78.9B

No single growth bet

Moderna, Inc. is valued on the income it pays out or on its book, not on one rate of revenue growth, so its price doesn't reduce to a single bet. The three stories below still show what it could be worth.

Both sides

Three stories, three values

Bear

$58

Base

$75

Bull

$84

Today $195

  • Bear $58. The margin takes 8 years to reach 16%, what a typical cash-making Health Care company makes. Sales grow 28% a year on average, as analysts expect.
  • Base $75. The margin reaches 16%, what a typical cash-making Health Care company makes, in 5 years. Sales grow 28% a year on average, as analysts expect.
  • Bull $84. The margin reaches 16% in only 3 years. Sales grow 28% a year on average, as analysts expect.

Stories set by rules from the company’s record.

At a glance

Healthcare · Biotechnology · listed on NASDAQ

Revenue, FY2025
$1.9B
Growth, 3 years a year
−30%
Cash margin
−106%
Net cash
$4.5B
Shares, 3-year change
−6.5%
Dividend yield
0%

What other healthcare prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.